Brodaty Henry, Chau Tiffany, Heffernan Megan, Ginige Jeewani A, Andrews Gavin, Millard Michael, Sachdev Perminder S, Anstey Kaarin J, Lautenschlager Nicola T, McNeil John J, Jorm Louisa, Kochan Nicole A, Maeder Anthony, Welberry Heidi, San Jose Juan Carlo, Briggs Nancy E, Popovic Gordana, Mavros Yorgi, Almendrales Rangel Carolina, Noble Yian, Radd-Vagenas Sue, Flood Victoria M, O'Leary Fiona, Lampit Amit, Walton Courtney C, Barr Polly, Fiatarone Singh Maria, Valenzuela Michael
Centre for Healthy Brain Ageing (CHeBA), School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
School of Computer, Data and Mathematical Sciences, Western Sydney University, Sydney, New South Wales, Australia.
Nat Med. 2025 Feb;31(2):565-573. doi: 10.1038/s41591-024-03351-6. Epub 2025 Jan 28.
Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55-77 years with modifiable dementia risk factors. Eligible participants (n = 6,104, 64% female) were randomized 1:1 to a personalized schedule of online coaching in two to four modules (targeting physical activity, nutrition, cognitive activity and depression or anxiety) or a control group that received module-eligible information only. At 3 years, the mean change in a global cognitive composite, the primary outcome, was met. The mean changes in z scores were 0.28 (95% confidence interval (CI): 0.25-0.32) for intervention, 0.10 (95% CI: 0.07-0.13) for control and 0.18 (95% CI: 0.13-0.23, P < 0.001) for the between-group difference. Trial-related adverse events occurred in 19 (0.60%) intervention and 1 (0.03%) control participant. Randomization of this internet-delivered lifestyle intervention tailored to individual dementia risk factors resulted in significantly better cognition in older adults over 3 years. This intervention is scalable with the potential for population-level rollout that may delay cognitive decline in the general community. Australian New Zealand ClinicalTrials.gov registration: ACTRN12618000851268.
鉴于痴呆症的全球负担以及开发疾病修饰疗法面临的挑战,需要有效的、可扩展的痴呆症预防干预措施来应对可改变的风险因素。一项单盲随机对照试验评估了一项在线多领域生活方式干预措施,以预防3年内的认知衰退。参与者为年龄在55 - 77岁、患有可改变的痴呆症风险因素且居住在社区的无痴呆症澳大利亚人。符合条件的参与者(n = 6104,64%为女性)被按1:1随机分配到一个包含两到四个模块(针对身体活动、营养、认知活动以及抑郁或焦虑)的个性化在线指导计划,或一个仅接收符合模块要求信息的对照组。在3年时,达到了主要结局——全球认知综合指标的平均变化。干预组的z分数平均变化为0.28(95%置信区间(CI):0.25 - 0.32),对照组为0.10(95% CI:0.07 - 0.13),组间差异为0.18(95% CI:0.13 - 0.23,P < 0.001)。与试验相关的不良事件发生在19名(0.60%)干预组参与者和1名(0.03%)对照组参与者中。针对个体痴呆症风险因素量身定制的这种互联网生活方式干预措施的随机分组,在3年时间里使老年人的认知能力显著提高。这种干预措施具有可扩展性,有可能在人群层面推广,从而可能延缓普通社区的认知衰退。澳大利亚新西兰临床试验注册中心注册号:ACTRN12618000851268。